Dr. Marten's stock is plummeting — and boots may be to blame

Posted
Consumers in the U.S. are holding off on purchasing boots — and Dr. Martens is bearing the brunt. Dr. Martens stock was down by more than 34% Tuesday morning, all the way $0.78 per share, after the company warned of a challenging fiscal year 2025 outlook and a decline in its U.S. wholesale market. Read more...

Continue reading at Quartz »

boots, business finance, martens, health medical pharma, fashion, dr martens, ije nwokorie, apple, north northamptonshire, kenny wilson